Both in Pharmaceuticals
Niagen Bioscience vs Sionna Therapeutics
Over the past year NAGE returned −70.2% and SION returned −82.6%; their daily moves had a correlation of 0.11.
NAGE −70.2% SION −82.6%Growth of $1, one year, split-adjusted
| Metric | NAGE | SION |
|---|---|---|
| Price | $2.95 | $5.15 |
| Market cap | $233.4M | $232.8M |
| Today | −1.01% | +0.59% |
| 1 month | −10.3% | −12.3% |
| 6 months | −31.1% | −86.0% |
| Year to date | −53.6% | −87.5% |
| 1 year | −69.8% | −82.2% |
| Revenue growth (YoY) | −4.3% | — |
| Gross margin | 64.8% | — |
| Net margin | 3.2% | — |
| P/E (TTM) | 14.6× | — |
| Price / sales | 1.8× | — |
| Net cash | $66.7M | $211.0M |
| Dividend yield | — | — |
| Volatility (60d) | 49.6% | 505.3% |
| Short % of float | 7.7% | 25.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).